Published 3 months ago

US FDA grants accelerated approval for Iovance's skin cancer cell therapy

The US Food and Drug Administration has approved a new therapy by Iovance Biotherapeutics to treat patients with metastatic melanoma, an incurable form of skin cancer.
The therapy, called Amtagvi, uses a patient's own immune cells to fight the cancer. It only needs to be administered once and can work for years.
In clinical trials, Amtagvi showed a 31.5% objective response rate, with some patients maintaining responses without tumor progression or death for up to 12 months.

Insights by Ground AI

Does this summary seem wrong?

0 Articles

All

Left

Center

Right

Reuters

US FDA grants accelerated approval for Iovance's skin cancer cell therapy

3 months ago·United Kingdom

Read Full Article

CNN

FDA approves new therapy for hard-to-treat metastatic melanoma

On Friday, the US Food and Drug Administration approved a new, first-of-its-kind therapy that could help patients with metastatic melanoma, a rare but deadly form of skin cancer.

3 months ago·Atlanta, United States

Read Full Article

KIFI

FDA approves new therapy for hard-to-treat metastatic melanoma

By Jen Christensen, CNN (CNN) — On Friday, the US Food and Drug Administration approved a new, first-of-its-kind therapy that could help patients with metastatic melanoma, a rare but deadly form of skin cancer. The drug, made by the California-based Iovance Biotherapeutics, is approved to treat patients for whom other medicines have failed and the skin cancer is unable to be removed with surgery, or the cancer has spread to other parts of the bo…

3 months ago·Idaho Falls, United States

Read Full Article

The Hill

FDA approves first cellular therapy to treat advanced melanoma

The Food and Drug Administration (FDA) announced Friday that it approved a ground breaking cellular therapy treatment for patients with advanced melanoma, and surgery has been unsuccessful. Amtagvi, a type of T-cell therapy, involves boosting immune cells within tumor tissue to help the body fight off the cancer. During the treatment, the patient’s t-cells are…

3 months ago·Washington, United States

Read Full Article

npr

FDA approves first cell therapy to treat aggressive forms of melanoma

Amtagvi is intended to help patients with melanoma that cannot be removed with surgery or has spread to other parts of the body.

3 months ago·Washington, United States

Read Full Article

NBC News

FDA approves groundbreaking treatment for advanced melanoma

The Food and Drug Administration on Friday approved a new cancer therapy that could one day transform the way a majority of aggressive and advanced tumors are treated.

3 months ago·United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year